"AI Scientists" - New Collaborators for Rare Disease Research?
In the quest to understand and treat the over 6,000 rare diseases, researchers encounter a number of limitations – in …
All Posts
Modi Ventures Closes $88M Second Fund for AI–Biology Convergence Investments
Modi Ventures has raised $88 million for its second fund, bringing total committed capital to over $134 million. The Houston-based …
Latent Labs Launches Web-Based AI Tool for Custom Protein Generation
Five months after emerging from stealth with $50 million in funding, Latent Labs has launched a web-based AI model Latent-X for programmable …
UK Rolls Out National Strategy to Build Europe’s Life Sciences Powerhouse by 2030
The UK government has released a new Industrial Strategy white paper outlining plans to strengthen the country’s life sciences sector. …
What are Foundation Models in Biology and Healthcare?
Content: History of AI in the Context of Foundation Models The Technology Stack Behind Foundation Models The Paradigm Shift in …
Japan’s Elix Launches AI Drug Discovery Platform Trained on Confidential Pharma Data via Federated Learning
Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on …
The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms
Artificial Intelligence (AI) is redefining the clinical trial process, offering solutions that address long-standing challenges in drug development. The traditional …
Google Expands MedGemma Collection With Multimodal Health AI Models for Open Development
Google Research has released two new models—MedGemma 27B Multimodal and MedSigLIP—as part of its open-source Health AI Developer Foundations (HAI-DEF) …
Xaira Therapeutics Appoints Biotech Exec Behind Belharra and Ambys as President and COO to Scale AI-Driven Drug Discovery Platform
Xaira Therapeutics, the AI-native biotech launched in 2024 with over $1 billion in funding, has appointed biotech executive Jeff Jonker …
NIH To End Funding for Animal-Only Studies, Backing Shift to New Approach Methodologies
The U.S. National Institutes of Health (NIH) will no longer fund new grant proposals that rely exclusively on animal testing, …
datma Launches Free Tool for Pharma to Assess Biomarker Coverage in Federated RWD
datma, a software company based in Beaverton, Oregon, focused on privacy-preserving federated data infrastructure, has launched the Federated Biomarker Explorer—a …
Building AI Solutions for Life Sciences and Healthcare
Artificial intelligence (AI) has swiftly become a focal point in modern industry discussions. Organizations are transitioning from mere experimentation to …